QLY Biotech Group Corp.
LQLY
$1.00
-$0.06-5.66%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 544.44% | 119.05% | 140.00% | 83.33% | -92.44% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 544.44% | 119.05% | 41.18% | 83.33% | -92.44% |
| Operating Income | -544.44% | -119.05% | -900.00% | -83.33% | 92.44% |
| Income Before Tax | -544.44% | -119.05% | -900.00% | -83.33% | 92.44% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -544.44% | -119.05% | -900.00% | -83.33% | 92.44% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -544.44% | -119.05% | -900.00% | -83.33% | 92.44% |
| EBIT | -544.44% | -119.05% | -900.00% | -83.33% | 92.44% |
| EBITDA | -792.31% | -139.47% | -900.00% | -83.33% | 94.51% |
| EPS Basic | -500.00% | -118.18% | -700.00% | -60.00% | 91.80% |
| Normalized Basic EPS | -533.33% | -114.29% | -900.00% | -66.67% | 92.11% |
| EPS Diluted | -500.00% | -118.18% | -700.00% | -60.00% | 91.80% |
| Normalized Diluted EPS | -533.33% | -114.29% | -900.00% | -66.67% | 92.11% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |